Debut Plus

543

-20.92 -3.71%

17 Jul 2026

NSE Listed

Panacea Biotec Ltd. (PANACEABIO)

Volume: 4,87,162Avg Vol 1W: 1,59,152Avg Vol 1M: 3,53,290.552W Range:292.4647
Key Ratios
Checked 6h ago
Market Cap₹3,454 Cr
Current Price₹543
Previous Close₹563.92
High / Low (52w)₹647 / ₹292.4
Volume4,87,162
Avg Vol (1W)1,59,152
Avg Vol (1M)3,53,290.5
Stock P/E7,049.38
Book Value₹136.3
Dividend Yield0%
ROE-292.7%
ROA-56.7%
Revenue (TTM)₹580 Cr
Revenue Growth0%
Profit Margin-83.9%
Total Debt₹15 Cr
Shares Outstanding6 Cr
Face Value₹1
EPS (TTM)₹0
P/B4.16
Debt / Equity0.02
50 DMA₹509.18
200 DMA₹405.56
Day change-3.71%
Price Chart
543 24.10% · 1Y
6082962.4Cr
2025-07-17
2026-07-16

20-day avg volume: 3.5L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 30% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 7049.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹116 Cr₹147 Cr₹163 Cr₹133 Cr₹167 Cr₹141 Cr₹165 Cr₹167 Cr
EBITDA₹-19 Cr₹3 Cr₹3 Cr₹-27 Cr₹-4 Cr₹-20 Cr₹6 Cr₹-3 Cr
Net Profit₹-16 Cr₹5 Cr₹5 Cr₹-2 Cr₹4 Cr₹-14 Cr₹4 Cr₹1 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹601 Cr₹461 Cr₹574 Cr₹635 Cr₹672 Cr₹512 Cr₹585 Cr₹580 Cr
EBITDA₹34 Cr₹-181 Cr₹18 Cr₹41 Cr₹-46 Cr₹-85 Cr₹-31 Cr₹-40 Cr
Net Profit₹-74 Cr₹38 Cr₹-194 Cr₹-148 Cr₹1,078 Cr₹-33 Cr₹-1 Cr₹-8 Cr
EPS-12.086.16-31.72-24.11176.05-5.43-0.19-1.37
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹1,608 Cr₹1,376 Cr₹1,390 Cr₹1,178 Cr₹1,759 Cr₹1,271 Cr₹1,241 Cr₹1,290 Cr
Total Liabilities₹1,302 Cr₹1,028 Cr₹1,195 Cr₹1,409 Cr₹885 Cr₹431 Cr₹402 Cr₹459 Cr
Equity₹306 Cr₹347 Cr₹196 Cr₹-232 Cr₹874 Cr₹840 Cr₹838 Cr₹831 Cr
Total Debt
Cash Flow
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹122 Cr₹103 Cr₹-22 Cr₹108 Cr₹295 Cr₹-420 Cr₹2 Cr₹-26 Cr
Investing₹55 Cr₹-5 Cr₹-35 Cr₹-48 Cr₹1,283 Cr₹430 Cr₹10 Cr₹65 Cr
Financing₹-164 Cr₹-101 Cr₹91 Cr₹-47 Cr₹-1,176 Cr₹-18 Cr₹-3 Cr₹-3 Cr
Free Cash Flow₹122 Cr₹103 Cr₹-22 Cr₹108 Cr₹295 Cr₹-420 Cr₹2 Cr₹-26 Cr
Shareholding
Promoter 72.48% Institutions 3.56% Public 23.96%
Efficiency & Working Capital
ROCE-2.4%
Interest Coverage-10.1
Dividend Payout
Debtor Days47 d
Inventory Days139 d
Payable Days147 d
Cash Conversion Cycle39 d
Working Capital Days187 d
Shareholding Details

As of 2026-03-31

Promoter72.5%
FII1.6%
DII2%
Institutions3.6%
Public24%
Promoter Pledge0%
No. of Shareholders32,620
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters73.6%73.6%73.6%73.6%73.5%72.9%72.5%72.5%72.5%72.5%72.5%72.5%
FIIs0.2%0.3%0.3%0.3%0.3%0.4%0.4%1.2%0.8%1.1%1.4%1.6%
DIIs0.5%0%0%0.8%1.1%1.2%1.2%1.5%1.5%1.8%1.9%2%
Public25.7%26.1%26.1%25.3%25.2%25.6%26%24.9%25.2%24.7%24.3%24%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders47,81548,87847,09146,24245,51339,98235,44633,59334,25633,59334,59732,620
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Dr. Rajesh JainShareholding of Promoter and Promoter Group49.3%3.02 Cr
Mr. Sandeep JainShareholding of Promoter and Promoter Group15.3%93,51,924
Mrs. Nirmala JainShareholding of Promoter and Promoter Group4.1%25,11,000
First Lucre Partnership Co.Shareholding of Promoter and Promoter Group3.7%22,55,815
Viral Amal ParikhPublic Shareholding1.5%8,99,341
Massachusetts Institute Of TechnologyPublic Shareholding1.1%6,85,000
Second Lucre Partnership Co.Shareholding of Promoter and Promoter Group0.1%57,639
Mrs. Meena JainShareholding of Promoter and Promoter Group0%0
Mrs. Pamilla JainShareholding of Promoter and Promoter Group0%0
Mr. Ankesh JainShareholding of Promoter and Promoter Group0%0
Mr. Harshet JainShareholding of Promoter and Promoter Group0%0
Mrs. Priyanka JainShareholding of Promoter and Promoter Group0%0
Rajesh Jain (huf) (karta : Rajesh Jain)Shareholding of Promoter and Promoter Group0%0
Sandeep Jain (huf) (karta : Sandeep Jain)Shareholding of Promoter and Promoter Group0%0
Mr. Abhey Kumar JainShareholding of Promoter and Promoter Group0%0
Mr. Ashish JainShareholding of Promoter and Promoter Group0%500
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Dr. Rajesh Jain00%2026-03-31
Mr. Sandeep Jain00%2026-03-31
Mrs. Nirmala Jain00%2026-03-31
Mrs. Meena Jain00%2026-03-31
Mrs. Pamilla Jain00%2026-03-31
Mr. Ankesh Jain00%2026-03-31
Mr. Harshet Jain00%2026-03-31
Mrs. Priyanka Jain00%2026-03-31
Rajesh Jain (huf) (karta : Rajesh Jain)00%2026-03-31
Sandeep Jain (huf) (karta : Sandeep Jain)00%2026-03-31
Mr. Abhey Kumar Jain00%2026-03-31
Mr. Ashish Jain00%2026-03-31
Board of Directors
NameDesignationYear
Rajesh JainChairman / Executive Director / M D / Promoter2025
Sandeep JainED / Joint MD / Promoter2025
Ankesh JainWTD & Executive Director2025
Harshet JainWTD & Executive Director2025
Sanjay TrehanExecutive Director / WTD - Technical2025
Ambika SharmaIndependent Non Exe. Director2025
Krishan Kumar JalanIndependent Non Exe. Director2025
Rajesh JainIndependent Non Exe. Director2025
Rajender Pal SinghIndependent Non Exe. Director2025
Venkatesh SarvasiddhiIndependent Non Exe. Director2025
Vinod GoelCS / Compliance Officer / Group CFO / Head - Legal2025
Segments — Product
SegmentRevenueShare
Vaccines₹96 Cr21.7%
Formulations₹348 Cr78.3%
Research and Development₹0 Cr0%
Segments — Geography
RegionRevenueShare
Domestic₹79 Cr82.3%
Overseas₹17 Cr17.7%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹11366
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20253880060394
20252300000230
20251440060150
Insider / Designated-Person Trades

30 recent disclosure(s)

Dr. Rajesh JainDisposal · 2,00,000
Rajesh Jain HUFAcquisition · 2,00,000
Nosheen SheikhAcquisition · 3,000
Sandeep JainDisposal · 5,000
Sandeep JainDisposal · 10,000
Rajesh JainAcquisition · 3,000
Substantial Acquisitions (SAST)

2 disclosure(s)

NULL12/06/2026 · 2,00,000
Market11/09/2023 · 13,34,520
Company Information
Incorporated1984
ChairmanRajesh Jain
AuditorSuresh Surana & Associates LLP/R & D
Investor Email[email protected]; investorgrievances@pa
🌐 www.panaceabiotec.com

📍 Ambala-Chandigarh Highway, Lalru, Punjab, 140501

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search